These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17761402)

  • 1. A possible link between dopamine action and myelin dysfunction in schizophrenia.
    Lindholm E; Jazin E
    Schizophr Res; 2007 Nov; 96(1-3):271-2. PubMed ID: 17761402
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia.
    Stewart DG; Davis KL
    Int Rev Neurobiol; 2004; 59():381-424. PubMed ID: 15006496
    [No Abstract]   [Full Text] [Related]  

  • 3. White matter changes in schizophrenia: evidence for myelin-related dysfunction.
    Davis KL; Stewart DG; Friedman JI; Buchsbaum M; Harvey PD; Hof PR; Buxbaum J; Haroutunian V
    Arch Gen Psychiatry; 2003 May; 60(5):443-56. PubMed ID: 12742865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
    Tkachev D; Mimmack ML; Ryan MM; Wayland M; Freeman T; Jones PB; Starkey M; Webster MJ; Yolken RH; Bahn S
    Lancet; 2003 Sep; 362(9386):798-805. PubMed ID: 13678875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myelin-pathogenesis puzzle in schizophrenia: a literature review.
    Karoutzou G; Emrich HM; Dietrich DE
    Mol Psychiatry; 2008 Mar; 13(3):245-60. PubMed ID: 17925796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways.
    Rietkerk T; Boks MP; Sommer IE; de Jong S; Kahn RS; Ophoff RA
    Mol Psychiatry; 2009 Apr; 14(4):353-5. PubMed ID: 19308022
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of synaptic connectivity reduction for pathogenesis, clinical picture and course of schizophrenia].
    Rabe-Jabłońska J
    Psychiatr Pol; 2003; 37(6):951-64. PubMed ID: 14727368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of oligodendrocyte and myelin genes is not altered in peripheral blood cells of patients with first-episode schizophrenia and bipolar disorder.
    Gutiérrez-Fernández A; González-Pinto A; Vega P; Barbeito S; Matute C
    Bipolar Disord; 2010 Feb; 12(1):107-9. PubMed ID: 20148873
    [No Abstract]   [Full Text] [Related]  

  • 9. Network analysis of positional candidate genes of schizophrenia highlights...more than... myelin-related pathways.
    Guilloux JP; Gaiteri C; Sibille E
    Mol Psychiatry; 2010 Aug; 15(8):786-8. PubMed ID: 20351722
    [No Abstract]   [Full Text] [Related]  

  • 10. Schizophrenia, myelination, and delayed corollary discharges: a hypothesis.
    Whitford TJ; Ford JM; Mathalon DH; Kubicki M; Shenton ME
    Schizophr Bull; 2012 May; 38(3):486-94. PubMed ID: 20855415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
    Davis KL; Haroutunian V
    Lancet; 2003 Sep; 362(9386):758. PubMed ID: 13678867
    [No Abstract]   [Full Text] [Related]  

  • 12. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients.
    Dracheva S; Davis KL; Chin B; Woo DA; Schmeidler J; Haroutunian V
    Neurobiol Dis; 2006 Mar; 21(3):531-40. PubMed ID: 16213148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hypothesis-driven pathway analysis reveals myelin-related pathways that contribute to the risk of schizophrenia and bipolar disorder.
    Yu H; Bi W; Liu C; Zhao Y; Zhang D; Yue W
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():140-5. PubMed ID: 24447946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor genes: new tools for molecular psychiatry.
    Niznik HB; Van Tol HH
    J Psychiatry Neurosci; 1992 Oct; 17(4):158-80. PubMed ID: 1450188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological evidence for lifelong brain development: a comment on Bartzokis.
    Feinberg I
    Neuropsychopharmacology; 2003 Jun; 28(6):1215-6. PubMed ID: 12700691
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for schizophrenia--all roads lead to dopamine.
    Di Forti M; Lappin JM; Murray RM
    Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S101-7. PubMed ID: 17336764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.
    Clinton SM; Ibrahim HM; Frey KA; Davis KL; Haroutunian V; Meador-Woodruff JH
    Am J Psychiatry; 2005 Oct; 162(10):1859-71. PubMed ID: 16199832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.
    Perlman WR; Weickert CS; Akil M; Kleinman JE
    J Psychiatry Neurosci; 2004 Jul; 29(4):287-93. PubMed ID: 15309045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological basis of schizophrenia: new directions.
    Weinberger DR
    J Clin Psychiatry; 1997; 58 Suppl 10():22-7. PubMed ID: 9265913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin, myelin-related disorders, and psychosis.
    Mighdoll MI; Tao R; Kleinman JE; Hyde TM
    Schizophr Res; 2015 Jan; 161(1):85-93. PubMed ID: 25449713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.